Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Early virologic outcomes and hematologic safety of direct-acting antiviral (DAA)-based therapy in US veterans with cirrhosis from hepatitis C virus (HCV) genotype 1 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Hwang, E. W., Thomas, I., Belperio, P. S., Cheung, R., Mole, L. A., Backus, L. I. WILEY-BLACKWELL. 2012: 1001A–1002A
View details for Web of Science ID 000310955603334